Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
30 May, 2017 02:23 IST
Divis Lab receives import alert for Visakhapatnam facility
Source: IRIS | 21 Mar, 2017, 10.10AM
Comments  |  Post Comment

Divis Laboratories, a pharmaceutical ingredients and intermediates company, has received an Import Alert 66-40 from US Food and Drug Administration (USFDA) for its products manufactured at the company's Unit-II located at Visakhapatnam, Andhra Pradesh on March 20, 2017.

The agency has exempted the following products from the Import Alert-Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium, Raltegravir potassium, Atovaquone, Chloropurine, BOC core succinate, 2, 4-wing active ester.

The company along with third party consultants is currently working to address the concerns of the USFDA and is making all efforts to fully meet the compliance requirements. 

Shares of the company declined Rs 138.7, or 17.54%, to trade at Rs 652.00. The total volume of shares traded was 1,228,420 at the BSE (10.02 a.m., Tuesday).



Divis Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Fitch affirms Bharti Airtel at 'BBB-' with 'Stable' outlook - 29-May-2017 14:07
Indian Hume Pipe secures work order worth Rs 2.01 bn - 29-May-2017 14:01
Reliance Comm swings to loss in Jan-Mar quarter - 29-May-2017 11:01
Tech Mahindra quarterly net drops 33% - 29-May-2017 10:51
Bank of Baroda to raise Rs 90 bn via equity dilution - 29-May-2017 09:58
Jindal Steel completes 6 MTPA integrated steel plant at Angul - 29-May-2017 09:46
Zydus receives final approval for Acamprosate Ca tablets - 29-May-2017 09:41
Glenmark Pharma gets final nod for generic Bystolic tablets - 29-May-2017 09:22
Strides Shasun completes USFDA inspection with 3 observations - 29-May-2017 09:18
Ashok Leyland turns to profit in Jan-Mar quarter - 26-May-2017 17:40
ITC Q4 profit climbs 12% to Rs 26.69 bn - 26-May-2017 16:50
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer